Effects of PNPLA3 I148M on hepatic lipid and very‐low‐density lipoprotein metabolism in humans

Background The phospholipase domain‐containing 3 gene (PNPLA3)‐148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride‐rich lipoproteins remains unclear. Here, we investigated the kinetics of large, triglyceride‐rich very‐low‐density lipoprotein (VLDL), (V...

Full description

Saved in:
Bibliographic Details
Published inJournal of internal medicine Vol. 291; no. 2; pp. 218 - 223
Main Authors Borén, Jan, Adiels, Martin, Björnson, Elias, Matikainen, Niina, Söderlund, Sanni, Rämö, Joel, Henricsson, Marcus, Ripatti, Pietari, Ripatti, Samuli, Palotie, Aarno, Mancina, Rosellina M., Ainola, Mari, Hakkarainen, Antti, Romeo, Stefano, Packard, Chris J., Taskinen, Marja‐Riitta
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.02.2022
Subjects
Online AccessGet full text
ISSN0954-6820
1365-2796
1365-2796
DOI10.1111/joim.13375

Cover

Loading…
Abstract Background The phospholipase domain‐containing 3 gene (PNPLA3)‐148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride‐rich lipoproteins remains unclear. Here, we investigated the kinetics of large, triglyceride‐rich very‐low‐density lipoprotein (VLDL), (VLDL1), and smaller VLDL2 in homozygotes for the PNPLA3‐148M variant. Methods and results The kinetics of apolipoprotein (apo) B100 (apoB100) and triglyceride in VLDL subfractions were analysed in nine subjects homozygous for PNPLA3‐148M and nine subjects homozygous for PNPLA3‐148I (controls). Liver fat was >3‐fold higher in the 148M subjects. Production rates for apoB100 and triglyceride in VLDL1 did not differ significantly between the two groups. Likewise, production rates for VLDL2‐apoB100 and ‐triglyceride, and fractional clearance rates for both apoB100 and triglyceride in VLDL1 and VLDL2, were not significantly different. Conclusions Despite the higher liver fat content in PNPLA3 148M homozygotes, there was no increase in VLDL production. Equally, VLDL production was maintained at normal levels despite the putative impairment in cytosolic lipid hydrolysis in these subjects.
AbstractList The PNPLA3-148M variant is associated with liver steatosis but its influence on metabolism of triglyceride-rich lipoproteins remains unclear. Here we investigated the kinetics of large, triglyceride-rich VLDL1 and smaller VLDL2 in homozygotes for the PNPLA3-148M variant.The kinetics of apoB100 and triglyceride in VLDL subfractions was analysed in nine subjects homozygous for PNPLA3-148M and nine subjects homozygous for PNPLA3-148I (controls). Liver fat was >3-fold higher in the 148M subjects. Production rates for apoB100 and triglyceride in VLDL1 did not differ significantly between the two groups. Likewise, production rates for VLDL2 -apoB100 and -triglyceride, and fractional clearance rates for both apoB100 and triglyceride in VLDL1 and VLDL2 , were not significantly different.Despite the higher liver fat content in PNPLA3-148M homozygotes, there was no increase in VLDL production. Equally, VLDL production was maintained at normal levels despite the putative impairment in cytosolic lipid hydrolysis in these subjects. This article is protected by copyright. All rights reserved.
The phospholipase domain-containing 3 gene (PNPLA3)-148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride-rich lipoproteins remains unclear. Here, we investigated the kinetics of large, triglyceride-rich very-low-density lipoprotein (VLDL), (VLDL ), and smaller VLDL in homozygotes for the PNPLA3-148M variant. The kinetics of apolipoprotein (apo) B100 (apoB100) and triglyceride in VLDL subfractions were analysed in nine subjects homozygous for PNPLA3-148M and nine subjects homozygous for PNPLA3-148I (controls). Liver fat was >3-fold higher in the 148M subjects. Production rates for apoB100 and triglyceride in VLDL did not differ significantly between the two groups. Likewise, production rates for VLDL -apoB100 and -triglyceride, and fractional clearance rates for both apoB100 and triglyceride in VLDL and VLDL , were not significantly different. Despite the higher liver fat content in PNPLA3 148M homozygotes, there was no increase in VLDL production. Equally, VLDL production was maintained at normal levels despite the putative impairment in cytosolic lipid hydrolysis in these subjects.
Background The phospholipase domain‐containing 3 gene (PNPLA3)‐148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride‐rich lipoproteins remains unclear. Here, we investigated the kinetics of large, triglyceride‐rich very‐low‐density lipoprotein (VLDL), (VLDL1), and smaller VLDL2 in homozygotes for the PNPLA3‐148M variant. Methods and results The kinetics of apolipoprotein (apo) B100 (apoB100) and triglyceride in VLDL subfractions were analysed in nine subjects homozygous for PNPLA3‐148M and nine subjects homozygous for PNPLA3‐148I (controls). Liver fat was >3‐fold higher in the 148M subjects. Production rates for apoB100 and triglyceride in VLDL1 did not differ significantly between the two groups. Likewise, production rates for VLDL2‐apoB100 and ‐triglyceride, and fractional clearance rates for both apoB100 and triglyceride in VLDL1 and VLDL2, were not significantly different. Conclusions Despite the higher liver fat content in PNPLA3 148M homozygotes, there was no increase in VLDL production. Equally, VLDL production was maintained at normal levels despite the putative impairment in cytosolic lipid hydrolysis in these subjects.
BackgroundThe phospholipase domain‐containing 3 gene (PNPLA3)‐148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride‐rich lipoproteins remains unclear. Here, we investigated the kinetics of large, triglyceride‐rich very‐low‐density lipoprotein (VLDL), (VLDL1), and smaller VLDL2 in homozygotes for the PNPLA3‐148M variant.Methods and resultsThe kinetics of apolipoprotein (apo) B100 (apoB100) and triglyceride in VLDL subfractions were analysed in nine subjects homozygous for PNPLA3‐148M and nine subjects homozygous for PNPLA3‐148I (controls). Liver fat was >3‐fold higher in the 148M subjects. Production rates for apoB100 and triglyceride in VLDL1 did not differ significantly between the two groups. Likewise, production rates for VLDL2‐apoB100 and ‐triglyceride, and fractional clearance rates for both apoB100 and triglyceride in VLDL1 and VLDL2, were not significantly different.ConclusionsDespite the higher liver fat content in PNPLA3 148M homozygotes, there was no increase in VLDL production. Equally, VLDL production was maintained at normal levels despite the putative impairment in cytosolic lipid hydrolysis in these subjects.
The phospholipase domain-containing 3 gene (PNPLA3)-148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride-rich lipoproteins remains unclear. Here, we investigated the kinetics of large, triglyceride-rich very-low-density lipoprotein (VLDL), (VLDL1 ), and smaller VLDL2 in homozygotes for the PNPLA3-148M variant.BACKGROUNDThe phospholipase domain-containing 3 gene (PNPLA3)-148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride-rich lipoproteins remains unclear. Here, we investigated the kinetics of large, triglyceride-rich very-low-density lipoprotein (VLDL), (VLDL1 ), and smaller VLDL2 in homozygotes for the PNPLA3-148M variant.The kinetics of apolipoprotein (apo) B100 (apoB100) and triglyceride in VLDL subfractions were analysed in nine subjects homozygous for PNPLA3-148M and nine subjects homozygous for PNPLA3-148I (controls). Liver fat was >3-fold higher in the 148M subjects. Production rates for apoB100 and triglyceride in VLDL1 did not differ significantly between the two groups. Likewise, production rates for VLDL2 -apoB100 and -triglyceride, and fractional clearance rates for both apoB100 and triglyceride in VLDL1 and VLDL2 , were not significantly different.METHODS AND RESULTSThe kinetics of apolipoprotein (apo) B100 (apoB100) and triglyceride in VLDL subfractions were analysed in nine subjects homozygous for PNPLA3-148M and nine subjects homozygous for PNPLA3-148I (controls). Liver fat was >3-fold higher in the 148M subjects. Production rates for apoB100 and triglyceride in VLDL1 did not differ significantly between the two groups. Likewise, production rates for VLDL2 -apoB100 and -triglyceride, and fractional clearance rates for both apoB100 and triglyceride in VLDL1 and VLDL2 , were not significantly different.Despite the higher liver fat content in PNPLA3 148M homozygotes, there was no increase in VLDL production. Equally, VLDL production was maintained at normal levels despite the putative impairment in cytosolic lipid hydrolysis in these subjects.CONCLUSIONSDespite the higher liver fat content in PNPLA3 148M homozygotes, there was no increase in VLDL production. Equally, VLDL production was maintained at normal levels despite the putative impairment in cytosolic lipid hydrolysis in these subjects.
Author Ainola, Mari
Borén, Jan
Adiels, Martin
Ripatti, Pietari
Rämö, Joel
Ripatti, Samuli
Palotie, Aarno
Söderlund, Sanni
Henricsson, Marcus
Hakkarainen, Antti
Matikainen, Niina
Packard, Chris J.
Mancina, Rosellina M.
Romeo, Stefano
Taskinen, Marja‐Riitta
Björnson, Elias
Author_xml – sequence: 1
  givenname: Jan
  orcidid: 0000-0003-0786-8091
  surname: Borén
  fullname: Borén, Jan
  email: jan.boren@wlab.gu.se
  organization: Sahlgrenska University Hospital
– sequence: 2
  givenname: Martin
  surname: Adiels
  fullname: Adiels, Martin
  organization: University of Gothenburg
– sequence: 3
  givenname: Elias
  surname: Björnson
  fullname: Björnson, Elias
  organization: University of Gothenburg
– sequence: 4
  givenname: Niina
  surname: Matikainen
  fullname: Matikainen, Niina
  organization: Helsinki University Hospital
– sequence: 5
  givenname: Sanni
  surname: Söderlund
  fullname: Söderlund, Sanni
  organization: Helsinki University Hospital
– sequence: 6
  givenname: Joel
  surname: Rämö
  fullname: Rämö, Joel
  organization: University of Helsinki
– sequence: 7
  givenname: Marcus
  surname: Henricsson
  fullname: Henricsson, Marcus
  organization: University of Gothenburg
– sequence: 8
  givenname: Pietari
  surname: Ripatti
  fullname: Ripatti, Pietari
  organization: University of Helsinki
– sequence: 9
  givenname: Samuli
  surname: Ripatti
  fullname: Ripatti, Samuli
  organization: University of Helsinki
– sequence: 10
  givenname: Aarno
  surname: Palotie
  fullname: Palotie, Aarno
  organization: Broad Institute of the Massachusetts Institute of Technology and Harvard University
– sequence: 11
  givenname: Rosellina M.
  surname: Mancina
  fullname: Mancina, Rosellina M.
  organization: University of Gothenburg
– sequence: 12
  givenname: Mari
  surname: Ainola
  fullname: Ainola, Mari
  organization: University of Helsinki
– sequence: 13
  givenname: Antti
  surname: Hakkarainen
  fullname: Hakkarainen, Antti
  organization: University of Helsinki
– sequence: 14
  givenname: Stefano
  surname: Romeo
  fullname: Romeo, Stefano
  organization: Sahlgrenska University Hospital
– sequence: 15
  givenname: Chris J.
  surname: Packard
  fullname: Packard, Chris J.
  organization: University of Glasgow
– sequence: 16
  givenname: Marja‐Riitta
  surname: Taskinen
  fullname: Taskinen, Marja‐Riitta
  organization: University of Helsinki
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34411351$$D View this record in MEDLINE/PubMed
https://gup.ub.gu.se/publication/306550$$DView record from Swedish Publication Index
BookMark eNp9kc1u1DAUhS1URKeFDQ-ALLFBSCn-T7KsqgKDprQLWFt2ct16lNghThjNjkfgGXkSPKRlUSG8sHXt71xdn3OCjkIMgNBLSs5oXu-20fdnlPNSPkErypUsWFmrI7QitRSFqhg5RicpbQmhnCjyDB1zISjlkq6QvXQOminh6PDN55vNOcdrKqorHAO-g8FMvsGdH3yLTWjxdxj3v3787OIu7y2E5Kf94TkOY5zAB9zDZGzsfOpxru7m3oT0HD11pkvw4v48RV_fX365-Fhsrj-sL843RSM4lYVtSlryltVlaSpZGqlaQSoKVnLpmkrwOlNQEylbcNaBcYwoZqvWuZbbUvJTVCx90w6G2eph9L0Z9zoar2_nQeer21kn0NkEKUnm3yx8Hv7bDGnSvU8NdJ0JEOekmVRcMMVrldHXj9BtnMeQf6OZYqQWnKs6U6_uqdn20P4d4MHtDJAFaMaY0ghON37KFscwjcZ3mhJ9CFQfAtV_As2St48kD13_CdMF3vkO9v8h9afr9dWi-Q17bLF8
CitedBy_id crossref_primary_10_1002_ueg2_12556
crossref_primary_10_1038_s41569_022_00676_y
crossref_primary_10_1177_20420188221145549
crossref_primary_10_1016_j_jhepr_2024_101185
crossref_primary_10_3390_biomedicines11071961
crossref_primary_10_1016_j_atherosclerosis_2023_117410
crossref_primary_10_1016_j_tem_2024_07_015
crossref_primary_10_1038_s41467_024_49224_x
crossref_primary_10_1111_liv_16117
crossref_primary_10_1146_annurev_nutr_062222_020716
Cites_doi 10.1038/s41575-019-0212-0
10.1161/ATVBAHA.107.160192
10.1074/jbc.RA118.002333
10.1210/jc.2005-1709
10.1002/oby.20366
10.1016/j.jhep.2020.03.039
10.1161/ATVBAHA.115.305614
10.1172/jci.insight.144079
10.1002/hep.30583
10.1152/ajpgi.00049.2020
10.1007/s00125-019-05024-3
10.1002/oby.20781
10.1007/s00125-005-0125-z
10.1016/j.jhep.2012.07.030
10.1093/eurheartj/ehx662
10.1111/joim.13017
10.1161/CIRCRESAHA.119.316337
10.1016/S0026-0495(96)90152-3
10.1194/jlr.M400108-JLR200
ContentType Journal Article
Copyright 2021 The Authors. published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
2021 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2021 The Authors. published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
– notice: 2021 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
– notice: 2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
C1K
K9.
7X8
ADTPV
AOWAS
F1U
DOI 10.1111/joim.13375
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
SwePub
SwePub Articles
SWEPUB Göteborgs universitet
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
MEDLINE

ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2796
EndPage 223
ExternalDocumentID oai_gup_ub_gu_se_306550
34411351
10_1111_joim_13375
JOIM13375
Genre shortCommunication
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
24P
29K
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
D-I
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IPNFZ
IX1
J0M
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SJN
SUPJJ
TEORI
TR2
UB1
V8K
V9Y
VH1
VVN
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZCG
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PKN
7QL
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
C1K
K9.
7X8
ADTPV
AOWAS
F1U
ID FETCH-LOGICAL-c4315-bc7173d2977a857a56d4081eb535fc8439315e9055defbfeaf2062b8dffd3b753
IEDL.DBID 24P
ISSN 0954-6820
1365-2796
IngestDate Thu Aug 21 06:30:00 EDT 2025
Thu Jul 10 22:05:22 EDT 2025
Fri Jul 25 21:18:02 EDT 2025
Wed Feb 19 02:26:44 EST 2025
Tue Jul 01 00:45:40 EDT 2025
Thu Apr 24 22:53:08 EDT 2025
Wed Jan 22 16:26:12 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords fatty liver
triglycerides
lipoproteins
lipid metabolism
Language English
License Attribution-NonCommercial-NoDerivs
2021 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4315-bc7173d2977a857a56d4081eb535fc8439315e9055defbfeaf2062b8dffd3b753
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-0786-8091
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjoim.13375
PMID 34411351
PQID 2620943369
PQPubID 30713
PageCount 6
ParticipantIDs swepub_primary_oai_gup_ub_gu_se_306550
proquest_miscellaneous_2563426396
proquest_journals_2620943369
pubmed_primary_34411351
crossref_citationtrail_10_1111_joim_13375
crossref_primary_10_1111_joim_13375
wiley_primary_10_1111_joim_13375_JOIM13375
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2022
PublicationDateYYYYMMDD 2022-02-01
PublicationDate_xml – month: 02
  year: 2022
  text: February 2022
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Journal of internal medicine
PublicationTitleAlternate J Intern Med
PublicationYear 2022
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 2015; 35
2020; 5
2018; 39
2006; 91
2018; 293
2013; 21
2020; 63
2020; 73
2006; 49
2019; 69
2008; 28
2020; 17
2020; 126
2020; 288
2012; 57
2014; 22
2005; 46
1996; 45
2020; 319
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_10_1
e_1_2_8_11_1
e_1_2_8_12_1
References_xml – volume: 22
  start-page: 1854
  year: 2014
  end-page: 9
  article-title: Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride‐rich lipoproteins
  publication-title: Obesity (Silver Spring)
– volume: 73
  start-page: 202
  year: 2020
  end-page: 9
  article-title: A new definition for metabolic dysfunction‐associated fatty liver disease: an international expert consensus statement
  publication-title: J Hepatol
– volume: 288
  start-page: 422
  year: 2020
  end-page: 38
  article-title: Apolipoprotein B48 metabolism in chylomicrons and very low‐density lipoproteins and its role in triglyceride transport in normo‐ and hypertriglyceridemic human subjects
  publication-title: J Intern Med.
– volume: 45
  start-page: 817
  year: 1996
  end-page: 21
  article-title: In vivo measurement of plasma cholesterol and fatty acid synthesis with deuterated water: determination of the average number of deuterium atoms incorporated
  publication-title: Metabolism.
– volume: 57
  start-page: 1276
  year: 2012
  end-page: 82
  article-title: Patatin‐like phospholipase domain‐containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
  publication-title: J Hepatol.
– volume: 49
  start-page: 755
  year: 2006
  end-page: 65
  article-title: Overproduction of large VLDL particles is driven by increased liver fat content in man
  publication-title: Diabetologia.
– volume: 35
  start-page: 2218
  year: 2015
  end-page: 24
  article-title: Kinetic and related determinants of plasma triglyceride concentration in abdominal obesity: multicenter tracer kinetic study
  publication-title: Arterioscler Thromb Vasc Biol.
– volume: 39
  start-page: 385
  year: 2018
  end-page: 93
  article-title: Liver fat content, non‐alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta‐analysis of 279 013 individuals
  publication-title: Eur Heart J.
– volume: 91
  start-page: 1446
  year: 2006
  end-page: 52
  article-title: Contributions of different fatty acid sources to very low‐density lipoprotein‐triacylglycerol in the fasted and fed states
  publication-title: J Clin Endocrinol Metab.
– volume: 69
  start-page: 2427
  year: 2019
  end-page: 41
  article-title: PNPLA3, CGI‐58, and inhibition of hepatic triglyceride hydrolysis in mice
  publication-title: Hepatology.
– volume: 46
  start-page: 58
  year: 2005
  end-page: 67
  article-title: A new combined multicompartmental model for apolipoprotein B‐100 and triglyceride metabolism in VLDL subfractions
  publication-title: J Lipid Res.
– volume: 63
  start-page: 253
  year: 2020
  end-page: 60
  article-title: Non‐alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality
  publication-title: Diabetologia.
– volume: 21
  start-page: 2138
  year: 2013
  end-page: 45
  article-title: A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population
  publication-title: Obesity (Silver Spring)
– volume: 17
  start-page: 40
  year: 2020
  end-page: 52
  article-title: Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
  publication-title: Nat Rev Gastroenterol Hepatol.
– volume: 5
  issue: 24
  year: 2020
  article-title: Effects of TM6SF2 E167K on hepatic lipid and very low‐density lipoprotein metabolism in humans
  publication-title: JCI Insight
– volume: 319
  start-page: G469
  year: 2020
  end-page: G80
  article-title: An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase
  publication-title: Am J Physiol Gastrointest Liver Physiol.
– volume: 126
  start-page: 679
  year: 2020
  end-page: 704
  article-title: Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases
  publication-title: Circ Res.
– volume: 28
  start-page: 1225
  year: 2008
  end-page: 36
  article-title: Overproduction of very low‐density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome
  publication-title: Arterioscler Thromb Vasc Biol.
– volume: 293
  start-page: 6958
  year: 2018
  end-page: 68
  article-title: Patatin‐like phospholipase domain‐containing protein 3 promotes transfer of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets
  publication-title: J Biol Chem.
– ident: e_1_2_8_2_1
  doi: 10.1038/s41575-019-0212-0
– ident: e_1_2_8_19_1
  doi: 10.1161/ATVBAHA.107.160192
– ident: e_1_2_8_6_1
  doi: 10.1074/jbc.RA118.002333
– ident: e_1_2_8_18_1
  doi: 10.1210/jc.2005-1709
– ident: e_1_2_8_3_1
  doi: 10.1002/oby.20366
– ident: e_1_2_8_4_1
  doi: 10.1016/j.jhep.2020.03.039
– ident: e_1_2_8_9_1
  doi: 10.1161/ATVBAHA.115.305614
– ident: e_1_2_8_10_1
  doi: 10.1172/jci.insight.144079
– ident: e_1_2_8_5_1
  doi: 10.1002/hep.30583
– ident: e_1_2_8_20_1
  doi: 10.1152/ajpgi.00049.2020
– ident: e_1_2_8_11_1
  doi: 10.1007/s00125-019-05024-3
– ident: e_1_2_8_16_1
  doi: 10.1002/oby.20781
– ident: e_1_2_8_8_1
  doi: 10.1007/s00125-005-0125-z
– ident: e_1_2_8_17_1
  doi: 10.1016/j.jhep.2012.07.030
– ident: e_1_2_8_12_1
  doi: 10.1093/eurheartj/ehx662
– ident: e_1_2_8_13_1
  doi: 10.1111/joim.13017
– ident: e_1_2_8_7_1
  doi: 10.1161/CIRCRESAHA.119.316337
– ident: e_1_2_8_15_1
  doi: 10.1016/S0026-0495(96)90152-3
– ident: e_1_2_8_14_1
  doi: 10.1194/jlr.M400108-JLR200
SSID ssj0013060
Score 2.4249966
Snippet Background The phospholipase domain‐containing 3 gene (PNPLA3)‐148M variant is associated with liver steatosis but its influence on the metabolism of...
The phospholipase domain-containing 3 gene (PNPLA3)-148M variant is associated with liver steatosis but its influence on the metabolism of triglyceride-rich...
BackgroundThe phospholipase domain‐containing 3 gene (PNPLA3)‐148M variant is associated with liver steatosis but its influence on the metabolism of...
The PNPLA3-148M variant is associated with liver steatosis but its influence on metabolism of triglyceride-rich lipoproteins remains unclear. Here we...
SourceID swepub
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 218
SubjectTerms Acyltransferases - genetics
Apolipoproteins
Cardiology and Cardiovascular Disease
Density
Fatty liver
Homozygotes
Humans
Kardiologi och kardiovaskulära sjukdomar
Kinetics
Lipid Metabolism
Lipids
Lipoproteins
Lipoproteins (very low density)
Lipoproteins, VLDL - metabolism
Liver
Liver - metabolism
Metabolism
Phospholipases A2, Calcium-Independent - genetics
Steatosis
Triglycerides
Triglycerides - metabolism
Title Effects of PNPLA3 I148M on hepatic lipid and very‐low‐density lipoprotein metabolism in humans
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjoim.13375
https://www.ncbi.nlm.nih.gov/pubmed/34411351
https://www.proquest.com/docview/2620943369
https://www.proquest.com/docview/2563426396
https://gup.ub.gu.se/publication/306550
Volume 291
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fa9RAEB9qC-JL8X9ja1lRBIVIyP7JBXwp2tIWrx5ioW9LNrvbBu6Sw9xR-uZH8DP6SZzZ5GJLRejLkmQnJOzsZH-TnfkNwBuVeGcyIYjoNouFJ5PywsaJt46XmSldKN82PlGHp-L4TJ6twcdVLkzHDzH8cCPLCN9rMvDCtNeNvKlmH9DDyuQ92KDcWqpfkIrJ3z2EJOQII4YQscKFricnDXE8w703l6NbGHMgEL2JXcPic_AQNnvUyPY6NT-CNVc_hvvjfl_8CZiOhLhljWeTk8mXPc6O0AMZs6ZmF46Cpks2reaVZUVtGc7eq98_f02bS2wtRbAvrqi7CaQNVc1mboFzY1q1M4ZnoYxf-xROD_a_fzqM--oJcYmgQMampA12myLAK0YyK6SyAtd_ZySnuC0EIijl8kRK67zxrvBpolIzst5bbtCLeQbrdVO7LWBGWp7Y0oyUQZt3ROiCwDy1We65zXgRwbvVIOqypxanChdTPbgYOOA6DHgErwfZeUeo8U-pnZUudG9UrSbu_FxwrvIIXg3daA60x1HUrlmijFScOOhzFcHzTofDYzhCPypIGMHbTqlDD3Fsny_nGi-dL3XrNM4ddN0ieB-U_p8X1cdfj8bh6MVdhLfhQUp5FCH8ewfWFz-W7iWim4XZDZMY28_f0j_GIvcP
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fi9QwEB_0BPVF_G_11IgiKFRK86fbx0M8ds_tug93cG-haZKzsNsudhe5Nz-Cn9FP4kzaqx6K4EtpmyktmZnmN8nkNwCvVOKdyYQgotssFp5cygsbJ946XmWmcqF8W7FQ0xNxdCpPh9wc2gvT80OME27kGeF_TQ5OE9K_e3lbr99hiJXJq3BNIDAno07F8tciQhI2CSOIELHCkW5gJw2JPOOzl8ejP0DmyCB6GbyG0efwNtwaYCM76PV8B6645i5cL4aF8XtgehbijrWeLRfL-QFnMwxBCtY27LOjrOmKrepNbVnZWIbme_7j2_dV-xWPllLYt-fU3AbWhrpha7dF41jV3ZrhVajj192Hk8MPx--n8VA-Ia4QFcjYVLTCblNEeOVEZqVUViAAcEZyStxCJIJSLk-ktM4b70qfJio1E-u95QbDmAew17SNewTMSMsTW5mJMuj0jhhdEJmnNss9txkvI3hz0Ym6GrjFqcTFSo8xBna4Dh0ewctRdtMzavxVav9CF3rwqk4TeX4uOFd5BC_GZvQHWuQoG9fuUEYqTiT0uYrgYa_D8TUcsR9VJIzgda_UsYVIts92G423zna6cxptB2O3CN4Gpf_jQ_XRp1kRzh7_j_BzuDE9LuZ6Plt8fAI3U9pUEXLB92Fv-2XnniLU2ZpnwaB_AmHY-Zs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fa9RAEB9qheKL-N_UqiuKoBAJ2T-5gC9FPXq1d96Dhb4t2exuDdwlR3OH9M2P4Gf0kzizyUWLIvhy5LITEnZmsr_JzP4G4IVKvDOZEER0m8XCk0t5YePEW8fLzJQutG-bztTRqTg-k2c78Ha7F6bjhxg-uJFnhPc1OfjK-t-dvKmWbzDCyuQ1uE7ZPiroS8X8Vw4hCXuEEUOIWOFC15OThjqe4dqry9EfGHMgEL2KXcPiM74FN3vUyA47Nd-GHVffgb1pnxe_C6YjIW5Z49l8Nj855GyCEciUNTX74qhoumSLalVZVtSWofVe_vj2fdF8xV9LFezrSxpuAmlDVbOlW6NtLKp2yfBfaOPX3oPT8YfP747ivntCXCIokLEpKcFuUwR4xUhmhVRW4PrvjORUt4VABKVcnkhpnTfeFT5NVGpG1nvLDUYx92G3bmr3EJiRlie2NCNl0OcdEbogME9tlntuM15E8Go7ibrsqcWpw8VCDyEGTrgOEx7B80F21RFq_FXqYKsL3TtVq4k7PxecqzyCZ8MwugPlOIraNRuUkYoTB32uInjQ6XC4DUfoRw0JI3jZKXUYIY7t881K46nzjW6dRtvB0C2C10Hp_3hQffxpMg1H-_8j_BT25u_H-mQy-_gIbqS0pSJUgh_A7vpi4x4j0FmbJ8GefwLbR_jE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+PNPLA3+I148M+on+hepatic+lipid+and+very%E2%80%90low%E2%80%90density+lipoprotein+metabolism+in+humans&rft.jtitle=Journal+of+internal+medicine&rft.au=Bor%C3%A9n%2C+Jan&rft.au=Adiels%2C+Martin&rft.au=Bj%C3%B6rnson%2C+Elias&rft.au=Matikainen%2C+Niina&rft.date=2022-02-01&rft.issn=0954-6820&rft.eissn=1365-2796&rft.volume=291&rft.issue=2&rft.spage=218&rft.epage=223&rft_id=info:doi/10.1111%2Fjoim.13375&rft.externalDBID=10.1111%252Fjoim.13375&rft.externalDocID=JOIM13375
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-6820&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-6820&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-6820&client=summon